RPRX

NASDAQ · Pharmaceuticals

Royalty Pharma Plc- Cl A

Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$57.31

-0.44 (-0.76%)

As of Aug 6, 9:37 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 88%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target -36.7% upside

Low Target $26.65

Average Target $36.26

High Target $40.53

Current Price $57.31

Current
$57.31

Target
$36.26

$26.65 $36.26 avg $40.53

Scenario Analysis

Bear Case

$26.65

-53.5%

Low target

Base Case

$36.26

-36.7%

Avg target

Bull Case

$40.53

+-29.3%

High target

Risk/Reward

0.5x

Unfavorable

Price in Context

52-Week High

$60.44

-5.2% from high

52-Week Low

$34.08

+68.2% from low

50-Day SMA

$40.77

+40.6% vs SMA

200-Day SMA

$37.28

+53.7% vs SMA

RSI (14)

85.1

Overbought

Target vs 52W High

$36.26

-40.0% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+11.9%
RDY Dr. Reddy's Laboratories	Sell	44	52%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+16.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.8%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+30.5%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+172.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.7%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+173.7%